
SPNS
Sapiens International Corporation NV
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
28.840
Open
28.840
VWAP
--
Vol
5.10K
Mkt Cap
1.61B
Low
28.840
Amount
--
EV/EBITDA(TTM)
13.47
Total Shares
55.73M
EV
1.44B
EV/OCF(TTM)
16.16
P/S(TTM)
2.98
Sapiens International Corporation N.V.is an Israel-based company engaged primary in the provision of software solutions for the insurance industry. The Company develops and maintains software for insurance companies, that helps resolving various general and market specific tasks related to the insurance sector. The Company's software is using artificial intelligence (AI) as well as advanced automation to resolve the tasks. The Company's software helps in a range of tasks such as: supporting core solutions for property and casualty, maintenance of workers compensation, financial and compliance, data and analytics, and decision management besides others. The Company is cooperating with specialists in information technology (IT) as well as insurance sectors.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
140.13M
+2.43%
0.320
-13.58%
147.89M
+7.93%
0.346
-6.42%
151.34M
+12.69%
0.371
+0.27%
Estimates Revision
The market is revising Upward the revenue expectations for Sapiens International Corporation N.V. (SPNS) for FY2025, with the revenue forecasts being adjusted by 2.63% over the past three months. During the same period, the stock price has changed by 5.29%.
Revenue Estimates for FY2025
Revise Upward

+2.63%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-0.72%
In Past 3 Month
Stock Price
Go Up

+5.29%
In Past 3 Month
4 Analyst Rating

6.35% Upside
Wall Street analysts forecast SPNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SPNS is 30.67 USD with a low forecast of 26.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
2 Sell
Hold

6.35% Upside
Current: 28.840

Low
26.00
Averages
30.67
High
35.00

6.35% Upside
Current: 28.840

Low
26.00
Averages
30.67
High
35.00
Barclays
Underweight
maintain
$28 -> $31
2025-05-09
Reason
Barclays
Price Target
$28 -> $31
2025-05-09
maintain
Underweight
Reason
Barclays raised the firm's price target on Sapiens to $31 from $28 and keeps an Underweight rating on the shares post the Q1 report. Sapiens is continuing with its strategy-optimizing product offerings and leveraging its existing customer base, this quarter making two acquisitions, the analyst tells investors in a research note. The firm thinks it is too early to become constructive on the shares.
Barclays
Tavy Rosner
Sell
Maintains
$30 → $28
2025-02-19
Reason
Barclays
Tavy Rosner
Price Target
$30 → $28
2025-02-19
Maintains
Sell
Reason
Barclays lowered the firm's price target on Sapiens to $28 from $30 and keeps an Underweight rating on the shares following the Q4 report. The firm says 2025 looks like a transition year for the company as management invests in generating higher growth through optimizing product offering, and leveraging its existing customer base.
Needham
Mayank Tandon
Strong Buy
Reiterates
$35
2025-02-19
Reason
Needham
Mayank Tandon
Price Target
$35
2025-02-19
Reiterates
Strong Buy
Reason
Jefferies
Surinder Thind
Strong Buy
to
Hold
Downgrades
$36 → $28
2025-02-03
Reason
Jefferies
Surinder Thind
Price Target
$36 → $28
2025-02-03
Downgrades
Strong Buy
to
Hold
Reason
Needham
Mayank Tandon
Strong Buy
Maintains
$44 → $35
2024-11-12
Reason
Needham
Mayank Tandon
Price Target
$44 → $35
2024-11-12
Maintains
Strong Buy
Reason
Barclays
Tavy Rosner
Sell
Maintains
$38 → $30
2024-11-12
Reason
Barclays
Tavy Rosner
Price Target
$38 → $30
2024-11-12
Maintains
Sell
Reason
Barclays lowered the firm's price target on Sapiens to $30 from $38 and keeps an Underweight rating on the shares. The company's lower than expected revenue and outlook were attributed to delays in software-as-a-service deal closings, among other things, the analyst tells investors in a research note. The firm reduced estimates post the print.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Sapiens International Corporation NV (SPNS.O) is 20.62, compared to its 5-year average forward P/E of 3.11. For a more detailed relative valuation and DCF analysis to assess Sapiens International Corporation NV 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
3.11
Current PE
20.62
Overvalued PE
10.34
Undervalued PE
-4.11
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
15.32
Current EV/EBITDA
14.46
Overvalued EV/EBITDA
18.45
Undervalued EV/EBITDA
12.19
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
3.04
Current PS
2.74
Overvalued PS
3.59
Undervalued PS
2.49
Financials
Annual
Quarterly
FY2025Q1
YoY :
+1.38%
136.11M
Total Revenue
FY2025Q1
YoY :
+5.36%
21.76M
Operating Profit
FY2025Q1
YoY :
+3.05%
18.03M
Net Income after Tax
FY2025Q1
YoY :
+3.23%
0.32
EPS - Diluted
FY2025Q1
YoY :
+41.36%
23.04M
Free Cash Flow
FY2025Q1
YoY :
+3.94%
44.57
Gross Profit Margin - %
FY2025Q1
YoY :
-100.00%
N/A
FCF Margin - %
FY2025Q1
YoY :
+1.61%
13.25
Net Margin - %
FY2025Q1
YoY :
+10.62%
14.89
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 200% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
600.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
SPNS News & Events
Events Timeline
2025-05-08 (ET)
2025-05-08
06:23:09
Sapiens raises FY25 revenue view to $574M-$578M from $553M-$558M

2025-05-08
06:21:07
Sapiens reports Q1 EPS 37c, consensus 35c

2025-04-28 (ET)
2025-04-28
13:33:17
Sapiens agrees to acquire AdvantageGo

Sign Up For More Events
Sign Up For More Events
News
8.0
07-28NASDAQ.COMStrategy To YieldBoost Sapiens International From 2.1% To 17.9% Using Options
9.5
07-23PRnewswireSAPIENS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 13, 2025
4.0
07-09NewsfilterSapiens Named as an AI Decisioning Platform leader in Analyst Evaluation
Sign Up For More News
People Also Watch

TCBK
Trico Bancshares
42.710
USD
0.00%

ADEA
Adeia Inc
12.960
USD
0.00%

LADR
Ladder Capital Corp
11.140
USD
0.00%

KRNT
Kornit Digital Ltd
20.760
USD
0.00%

SRCE
1st Source Corp
61.420
USD
0.00%

LZ
LegalZoom.com Inc
9.170
USD
0.00%

WT
WisdomTree Inc
13.455
USD
+0.56%

AHCO
Adapthealth Corp
9.330
USD
0.00%

MMI
Marcus & Millichap Inc
32.500
USD
0.00%

UHAL
U-Haul Holding Co
61.070
USD
-1.26%
FAQ

What is Sapiens International Corporation NV (SPNS) stock price today?
The current price of SPNS is 28.84 USD — it has increased 0 % in the last trading day.

What is Sapiens International Corporation NV (SPNS)'s business?

What is the price predicton of SPNS Stock?

What is Sapiens International Corporation NV (SPNS)'s revenue for the last quarter?

What is Sapiens International Corporation NV (SPNS)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Sapiens International Corporation NV (SPNS)'s fundamentals?

How many employees does Sapiens International Corporation NV (SPNS). have?
